Metastatic Brain Tumors: Radiosurgery – Treatment
Über den Vortrag
Der Vortrag „Metastatic Brain Tumors: Radiosurgery – Treatment“ von Roy Strowd, MD ist Bestandteil des Kurses „CNS Tumors“.
Quiz zum Vortrag
Which of the following characterizes stereotactic radiosurgery (SRS)?
- High rate of out-of-field recurrence
- Treats the whole brain
- High rate of post-radiotherapy neurocognitive decline
- Can treat microscopic disease not observed on MRI
- Relatively inexpensive to perform
Which of the following would be an indication for whole-brain radiation therapy (WBRT).
- Progressive leptomeningeal disease
- > 5 brain metastases
- Severely obtunded patients showing no signs of improvement after corticosteroids
- > 15 brain metastases and innumerable lung metastases
- Life expectancy < 3 months due to extracranial disease
Which of the following is true about stereotactic radiosurgery (SRS)?
- Radiation necrosis is a potential side effect.
- Treatment requires multiple sessions.
- It is poorly efficacious.
- It is Indicated if there are more than 15 brain metastases.
- After treatment, brain metastases rarely reoccur.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Metastatic Brain Tumors: Radiosurgery – Treatment
Roy Strowd, MD
Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
